Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Jamie Samath Sells 22,903 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Jamie Samath also recently made the following trade(s):

• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $1.32 during midday trading on Tuesday, hitting $537.07. The company’s stock had a trading volume of 1,455,926 shares, compared to its average volume of 1,459,553. The stock has a market capitalization of $191.29 billion, a price-to-earnings ratio of 86.13, a PEG ratio of 5.27 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $281.12 and a fifty-two week high of $542.59. The stock’s 50 day simple moving average is $494.78 and its 200 day simple moving average is $453.94.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price target for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Barclays lifted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Finally, Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of ISRG. Alpha DNA Investment Management LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth $719,000. Larson Financial Group LLC increased its stake in shares of Intuitive Surgical by 79.4% in the third quarter. Larson Financial Group LLC now owns 854 shares of the medical equipment provider’s stock worth $420,000 after purchasing an additional 378 shares during the period. Swedbank AB boosted its stake in shares of Intuitive Surgical by 1.7% in the 3rd quarter. Swedbank AB now owns 180,043 shares of the medical equipment provider’s stock valued at $88,450,000 after purchasing an additional 2,944 shares in the last quarter. Algert Global LLC bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $1,988,000. Finally, Cerity Partners LLC increased its stake in Intuitive Surgical by 10.5% during the 3rd quarter. Cerity Partners LLC now owns 139,175 shares of the medical equipment provider’s stock worth $68,372,000 after purchasing an additional 13,188 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.